Skip to main navigation Skip to search Skip to main content

Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels

  • DISTAL Investigators
  • University Hospital Basel
  • University of Basel
  • Hospital Universitari Vall d'Hebron
  • Universitat Autònoma de Barcelona (UAB)
  • Helsinki University Central Hospital
  • Valladolid University Hospital
  • Centre Hospitalier Universitaire Vaudois
  • Inselspital Universitatsspital
  • Universitätsklinikum Carl Gustav Carus Dresden
  • Universitair Ziekenhuis Brussel
  • Centre Hospitalier Universitaire Charleroi
  • Klinikum Stuttgart
  • Hospital Universitario Virgen de la Arrixaca
  • Technical University of Munich
  • Universitätsklinikum Hamburg-Eppendorf
  • University of Leuven
  • Leuven University Center for Metabolic Bone Diseases
  • Cantonal Hospital of Lucerne
  • Leiden University Medical Centre
  • University Neurovascular Center Leiden-the Hague
  • Amsterdam University Medical Centers
  • University Hospital Germans Trias i Pujol
  • University of Münster
  • University of Lübeck
  • Maastricht University Medical Center
  • Ghent University Hospital
  • Charité – Universitätsmedizin Berlin
  • Geneva University Hospitals
  • Klinikum Vest
  • Asklepios-Klinik St. Georg
  • CHRU de Tours
  • Zentralkrankenhaus Bremen-Mitte
  • Aretaieion University Hospital
  • Universitätsmedizin Mannheim
  • Department of Diagnostic and Interventional Neuroradiology
  • Ospedale Maggiore
  • Unit of Gastroenterology SOD2
  • Klinikum der J. W. Goethe-Universität
  • Westeinde Hospital
  • Cantonal Hospital St Gallen
  • Hospital Universitari de Girona Dr. Josep Trueta
  • University Hospital
  • Hospital Clinic Barcelona
  • Central University Hospital Lisboa
  • Hadassah Hebrew University Medical Center
  • David Geffen School of Medicine at UCLA

Research output: Contribution to journalArticlepeer-review

185 Scopus citations

Abstract

Background Endovascular treatment (EVT) of stroke with large-vessel occlusion is known to be safe and effective. The effect of EVT for occlusion of medium or distal vessels is unclear. Methods We randomly assigned participants with an isolated occlusion of medium or distal vessels (occlusion of the nondominant or codominant M2 segment of the middle cerebral artery [MCA]; the M3 or M4 segment of the MCA; the A1, A2, or A3 segment of the anterior cerebral artery; or the P1, P2, or P3 segment of the posterior cerebral artery) to receive EVT plus best medical treatment or best medical treatment alone within 24 hours after the participant was last seen to be well. The primary outcome was the level of disability at 90 days, as assessed with the modified Rankin scale score. Results A total of 543 participants (women, 44%; median age, 77 years) were included in the analysis: 271 were assigned to receive EVT plus best medical treatment and 272 to receive best medical treatment alone. The median score on the National Institutes of Health Stroke Scale (range, 0 to 42, with higher scores indicating more severe symptoms) at admission was 6 (interquartile range, 5 to 9). Intravenous thrombolysis was given to 65.4% of the participants. The predominant occlusion locations were the M2 segment (in 44.0% of the participants), M3 segment (in 26.9%), P2 segment (in 13.4%), and P1 segment (in 5.5%). In the comparison between EVT plus best medical treatment and best medical treatment alone, no significant difference in the distribution of modified Rankin scale scores was observed at 90 days (common odds ratio for improvement in the score, 0.90; 95% confidence interval, 0.67 to 1.22; P=0.50). All-cause mortality was similar in the two groups (15.5% with EVT plus best medical treatment and 14.0% with best medical treatment alone), as was the incidence of symptomatic intracranial hemorrhage (5.9% and 2.6%, respectively). Conclusions In persons with stroke with occlusion of medium or distal vessels, EVT did not result in a lower level of disability or a lower incidence of death than best medical treatment alone.

Original languageEnglish
Pages (from-to)1374-1384
Number of pages11
JournalNew England Journal of Medicine
Volume392
Issue number14
DOIs
StatePublished - 10 Apr 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels'. Together they form a unique fingerprint.

Cite this